• Bloom Burton & Co. Healthcare Investor Conference -
April 21st at 10:00 a.m. EST •
• Planet MicroCap Showcase - April
22nd at 10:00 a.m.
EST •
MISSISSAUGA, ON, April 9, 2021 /CNW/ - April 9, 2021 – Nuvo
Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a
Miravo Healthcare (Miravo or the Company), a Canadian focused
healthcare company with global reach and a diversified portfolio of
commercial products, today announced Jesse
Ledger, Miravo's President & Chief Executive Officer and
Mary-Jane Burkett, Miravo's Vice
President & Chief Financial Officer will be presenting at
upcoming investor conferences.
Bloom Burton & Co. Healthcare Investor
Conference
The Bloom Burton & Co. Healthcare Investor
Conference brings together U.S., Canadian and international
investors who are interested in the latest developments in the
Canadian healthcare sector. Attendees will have an opportunity to
obtain corporate updates from the premier Canadian publicly traded
and private companies through presentations and private
meetings.
|
Miravo Healthcare
Presentation
|
|
|
|
DATE:
|
Wednesday, April
21st, 2021
|
|
TIME:
|
10:00 a.m.
EST
|
|
LINK:
|
Conference
Registration
|
Planet MicroCap Showcase
The Planet MicroCap Showcase VIRTUAL EVENT brings together the
most promising companies and the top dealmakers in MicroCap Finance
for three (3) days of company presentations, 1:1 meetings and
educational panels in The Premier Virtual Event in MicroCap
Finance.
|
Miravo Healthcare Presentation
|
|
|
|
DATE:
|
Thursday, April 22nd,
2021
|
|
TIME:
|
10:00 a.m.
EST
|
|
LINK:
|
Miravo
Presentation
|
About Miravo Healthcare
Miravo is a Canadian focused,
healthcare company with global reach and a diversified portfolio of
commercial products. The Company's products target several
therapeutic areas, including pain, allergy, neurology and
dermatology. The Company's strategy is to in-license and
acquire growth-oriented, complementary products for Canadian and
international markets. Miravo's head office is located in
Mississauga, Ontario, Canada, the
international operations are located in Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The
Varennes facility operates in a
Good Manufacturing Practices (GMP) environment respecting the U.S,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.miravohealthcare.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-present-at-upcoming-investor-conferences-301265571.html
SOURCE Nuvo Pharmaceuticals Inc.